nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—chronic obstructive pulmonary disease	0.323	0.509	CbGaD
Albendazole—CYP1A2—chronic obstructive pulmonary disease	0.312	0.491	CbGaD
Albendazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0481	0.209	CbGbCtD
Albendazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0391	0.17	CbGbCtD
Albendazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0264	0.115	CbGbCtD
Albendazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0252	0.11	CbGbCtD
Albendazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0224	0.0978	CbGbCtD
Albendazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.022	0.0958	CbGbCtD
Albendazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0208	0.0905	CbGbCtD
Albendazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0132	0.0574	CbGbCtD
Albendazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0124	0.0542	CbGbCtD
Albendazole—TUBA1A—respiratory system—chronic obstructive pulmonary disease	0.0023	0.0986	CbGeAlD
Albendazole—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00228	0.0555	CbGpPWpGaD
Albendazole—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.0326	CcSEcCtD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00213	0.052	CbGpPWpGaD
Albendazole—Mebendazole—CYP1A1—chronic obstructive pulmonary disease	0.0021	1	CrCbGaD
Albendazole—TUBA1A—connective tissue—chronic obstructive pulmonary disease	0.00202	0.0868	CbGeAlD
Albendazole—TUBA1A—bronchus—chronic obstructive pulmonary disease	0.00189	0.0812	CbGeAlD
Albendazole—Intracranial pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.0273	CcSEcCtD
Albendazole—TUBA1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00185	0.0794	CbGeAlD
Albendazole—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00177	0.0433	CbGpPWpGaD
Albendazole—TUBA1A—trachea—chronic obstructive pulmonary disease	0.0017	0.0729	CbGeAlD
Albendazole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00155	0.0378	CbGpPWpGaD
Albendazole—TUBB4B—respiratory system—chronic obstructive pulmonary disease	0.00153	0.0657	CbGeAlD
Albendazole—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.0219	CcSEcCtD
Albendazole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00137	0.0334	CbGpPWpGaD
Albendazole—Intracranial pressure increased—Prednisone—chronic obstructive pulmonary disease	0.00136	0.0198	CcSEcCtD
Albendazole—TUBB4B—connective tissue—chronic obstructive pulmonary disease	0.00135	0.0579	CbGeAlD
Albendazole—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.0188	CcSEcCtD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00129	0.0314	CbGpPWpGaD
Albendazole—TUBB4B—bronchus—chronic obstructive pulmonary disease	0.00126	0.0541	CbGeAlD
Albendazole—TUBB4B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00123	0.0529	CbGeAlD
Albendazole—TUBA1A—lung—chronic obstructive pulmonary disease	0.00122	0.0524	CbGeAlD
Albendazole—TUBB4B—trachea—chronic obstructive pulmonary disease	0.00113	0.0486	CbGeAlD
Albendazole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00112	0.0273	CbGpPWpGaD
Albendazole—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.0163	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.0153	CcSEcCtD
Albendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.0253	CbGpPWpGaD
Albendazole—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000987	0.0144	CcSEcCtD
Albendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000945	0.0231	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000941	0.023	CbGpPWpGaD
Albendazole—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000888	0.0129	CcSEcCtD
Albendazole—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000882	0.0128	CcSEcCtD
Albendazole—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000869	0.0373	CbGeAlD
Albendazole—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000858	0.0368	CbGeAlD
Albendazole—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000843	0.0123	CcSEcCtD
Albendazole—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000831	0.0121	CcSEcCtD
Albendazole—TUBB4B—lung—chronic obstructive pulmonary disease	0.000813	0.0349	CbGeAlD
Albendazole—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000812	0.0118	CcSEcCtD
Albendazole—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000807	0.0117	CcSEcCtD
Albendazole—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000803	0.0117	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000785	0.0114	CcSEcCtD
Albendazole—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000749	0.0109	CcSEcCtD
Albendazole—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000748	0.0109	CcSEcCtD
Albendazole—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000717	0.0104	CcSEcCtD
Albendazole—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.0104	CcSEcCtD
Albendazole—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000711	0.0104	CcSEcCtD
Albendazole—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000711	0.0104	CcSEcCtD
Albendazole—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000711	0.0103	CcSEcCtD
Albendazole—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000706	0.0303	CbGeAlD
Albendazole—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000704	0.0172	CbGpPWpGaD
Albendazole—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000702	0.0102	CcSEcCtD
Albendazole—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000697	0.0101	CcSEcCtD
Albendazole—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.00985	CcSEcCtD
Albendazole—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000672	0.00978	CcSEcCtD
Albendazole—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000672	0.00977	CcSEcCtD
Albendazole—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00977	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00963	CcSEcCtD
Albendazole—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000658	0.0161	CbGpPWpGaD
Albendazole—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000656	0.00954	CcSEcCtD
Albendazole—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.00954	CcSEcCtD
Albendazole—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000646	0.0094	CcSEcCtD
Albendazole—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000642	0.00934	CcSEcCtD
Albendazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000641	0.00932	CcSEcCtD
Albendazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00064	0.00931	CcSEcCtD
Albendazole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000636	0.00926	CcSEcCtD
Albendazole—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000634	0.0272	CbGeAlD
Albendazole—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000621	0.00903	CcSEcCtD
Albendazole—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00901	CcSEcCtD
Albendazole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00878	CcSEcCtD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000597	0.0146	CbGpPWpGaD
Albendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000596	0.0146	CbGpPWpGaD
Albendazole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000569	0.0139	CbGpPWpGaD
Albendazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000565	0.0138	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000554	0.00806	CcSEcCtD
Albendazole—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000543	0.0132	CbGpPWpGaD
Albendazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000538	0.00783	CcSEcCtD
Albendazole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.0078	CcSEcCtD
Albendazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00779	CcSEcCtD
Albendazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00779	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000534	0.00777	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.00777	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00761	CcSEcCtD
Albendazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.0076	CcSEcCtD
Albendazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00738	CcSEcCtD
Albendazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00735	CcSEcCtD
Albendazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00729	CcSEcCtD
Albendazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00729	CcSEcCtD
Albendazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000499	0.00726	CcSEcCtD
Albendazole—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000499	0.0122	CbGpPWpGaD
Albendazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00719	CcSEcCtD
Albendazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000491	0.00714	CcSEcCtD
Albendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000481	0.0117	CbGpPWpGaD
Albendazole—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00048	0.0117	CbGpPWpGaD
Albendazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00688	CcSEcCtD
Albendazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.00685	CcSEcCtD
Albendazole—CYP1A2—lung—chronic obstructive pulmonary disease	0.000462	0.0198	CbGeAlD
Albendazole—CYP1A1—lung—chronic obstructive pulmonary disease	0.000455	0.0195	CbGeAlD
Albendazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000448	0.00652	CcSEcCtD
Albendazole—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000445	0.0191	CbGeAlD
Albendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000438	0.0107	CbGpPWpGaD
Albendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000436	0.0106	CbGpPWpGaD
Albendazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00627	CcSEcCtD
Albendazole—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000429	0.0105	CbGpPWpGaD
Albendazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000427	0.00621	CcSEcCtD
Albendazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000427	0.00621	CcSEcCtD
Albendazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00617	CcSEcCtD
Albendazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00615	CcSEcCtD
Albendazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00613	CcSEcCtD
Albendazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00613	CcSEcCtD
Albendazole—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000416	0.0102	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00601	CcSEcCtD
Albendazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00596	CcSEcCtD
Albendazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00596	CcSEcCtD
Albendazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00593	CcSEcCtD
Albendazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00593	CcSEcCtD
Albendazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00593	CcSEcCtD
Albendazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00593	CcSEcCtD
Albendazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00591	CcSEcCtD
Albendazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00586	CcSEcCtD
Albendazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000402	0.00586	CcSEcCtD
Albendazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00585	CcSEcCtD
Albendazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00584	CcSEcCtD
Albendazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00582	CcSEcCtD
Albendazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00581	CcSEcCtD
Albendazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00581	CcSEcCtD
Albendazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00579	CcSEcCtD
Albendazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00563	CcSEcCtD
Albendazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.0056	CcSEcCtD
Albendazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.0056	CcSEcCtD
Albendazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00553	CcSEcCtD
Albendazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00553	CcSEcCtD
Albendazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00552	CcSEcCtD
Albendazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00541	CcSEcCtD
Albendazole—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000371	0.00904	CbGpPWpGaD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000361	0.0088	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000359	0.00876	CbGpPWpGaD
Albendazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00522	CcSEcCtD
Albendazole—TUBA1A—p73 transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000358	0.00874	CbGpPWpGaD
Albendazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00496	CcSEcCtD
Albendazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00496	CcSEcCtD
Albendazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000338	0.00825	CbGpPWpGaD
Albendazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00486	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000334	0.00815	CbGpPWpGaD
Albendazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00485	CcSEcCtD
Albendazole—ABCB1—trachea—chronic obstructive pulmonary disease	0.000329	0.0141	CbGeAlD
Albendazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00477	CcSEcCtD
Albendazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00477	CcSEcCtD
Albendazole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.00796	CbGpPWpGaD
Albendazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00473	CcSEcCtD
Albendazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00473	CcSEcCtD
Albendazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00473	CcSEcCtD
Albendazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00473	CcSEcCtD
Albendazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.0047	CcSEcCtD
Albendazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000323	0.0047	CcSEcCtD
Albendazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00468	CcSEcCtD
Albendazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00467	CcSEcCtD
Albendazole—TUBB4B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00032	0.00781	CbGpPWpGaD
Albendazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00463	CcSEcCtD
Albendazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00463	CcSEcCtD
Albendazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000316	0.0046	CcSEcCtD
Albendazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0045	CcSEcCtD
Albendazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.00447	CcSEcCtD
Albendazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00447	CcSEcCtD
Albendazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00446	CcSEcCtD
Albendazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00446	CcSEcCtD
Albendazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00446	CcSEcCtD
Albendazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00444	CcSEcCtD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000305	0.00744	CbGpPWpGaD
Albendazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00436	CcSEcCtD
Albendazole—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000297	0.00724	CbGpPWpGaD
Albendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.00716	CbGpPWpGaD
Albendazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00421	CcSEcCtD
Albendazole—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000287	0.00701	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000284	0.00693	CbGpPWpGaD
Albendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000276	0.00674	CbGpPWpGaD
Albendazole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00652	CbGpPWpGaD
Albendazole—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000265	0.00647	CbGpPWpGaD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000261	0.00636	CbGpPWpGaD
Albendazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00375	CcSEcCtD
Albendazole—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00625	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00625	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00625	CbGpPWpGaD
Albendazole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00624	CbGpPWpGaD
Albendazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00367	CcSEcCtD
Albendazole—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.00614	CbGpPWpGaD
Albendazole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000246	0.00599	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.00585	CbGpPWpGaD
Albendazole—ABCB1—lung—chronic obstructive pulmonary disease	0.000237	0.0102	CbGeAlD
Albendazole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00576	CbGpPWpGaD
Albendazole—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000231	0.00564	CbGpPWpGaD
Albendazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00325	CcSEcCtD
Albendazole—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00542	CbGpPWpGaD
Albendazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00323	CcSEcCtD
Albendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.0052	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000212	0.00517	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00306	CcSEcCtD
Albendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00506	CbGpPWpGaD
Albendazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00299	CcSEcCtD
Albendazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000205	0.005	CbGpPWpGaD
Albendazole—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00499	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000202	0.00492	CbGpPWpGaD
Albendazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00287	CcSEcCtD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000194	0.00474	CbGpPWpGaD
Albendazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00474	CbGpPWpGaD
Albendazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00269	CcSEcCtD
Albendazole—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000183	0.00447	CbGpPWpGaD
Albendazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00435	CbGpPWpGaD
Albendazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00256	CcSEcCtD
Albendazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00256	CcSEcCtD
Albendazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00255	CcSEcCtD
Albendazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00419	CbGpPWpGaD
Albendazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00419	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000171	0.00418	CbGpPWpGaD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.0041	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00241	CcSEcCtD
Albendazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00241	CcSEcCtD
Albendazole—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000163	0.00397	CbGpPWpGaD
Albendazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00235	CcSEcCtD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00392	CbGpPWpGaD
Albendazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00233	CcSEcCtD
Albendazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00233	CcSEcCtD
Albendazole—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.00015	0.00365	CbGpPWpGaD
Albendazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00218	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000148	0.00362	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000138	0.00338	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000136	0.00331	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000135	0.0033	CbGpPWpGaD
Albendazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00195	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000131	0.00319	CbGpPWpGaD
Albendazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00188	CcSEcCtD
Albendazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00186	CcSEcCtD
Albendazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00186	CcSEcCtD
Albendazole—Headache—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00185	CcSEcCtD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000126	0.00308	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00308	CbGpPWpGaD
Albendazole—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00175	CcSEcCtD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000119	0.0029	CbGpPWpGaD
Albendazole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.0029	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.0029	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.0029	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000117	0.00287	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00286	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000116	0.00282	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00271	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000109	0.00266	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.00262	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000106	0.00259	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000104	0.00254	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000103	0.00251	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00249	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000102	0.00248	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00246	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.72e-05	0.00237	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.67e-05	0.00236	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.6e-05	0.00234	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.47e-05	0.00231	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	9.34e-05	0.00228	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.16e-05	0.00224	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.01e-05	0.0022	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.92e-05	0.00218	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.8e-05	0.00215	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8.72e-05	0.00213	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	8.4e-05	0.00205	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.00202	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	8.13e-05	0.00198	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.11e-05	0.00198	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	8e-05	0.00195	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	7.9e-05	0.00193	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.85e-05	0.00192	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.85e-05	0.00192	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.78e-05	0.0019	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.59e-05	0.00185	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.55e-05	0.00184	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	7.47e-05	0.00182	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.47e-05	0.00182	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.45e-05	0.00182	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.44e-05	0.00182	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.00181	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.34e-05	0.00179	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.00178	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	7.09e-05	0.00173	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.04e-05	0.00172	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.84e-05	0.00167	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.84e-05	0.00167	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.77e-05	0.00165	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.74e-05	0.00165	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.57e-05	0.0016	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.00147	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.56e-05	0.00136	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.56e-05	0.00136	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.4e-05	0.00132	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.34e-05	0.0013	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.28e-05	0.00129	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.22e-05	0.00127	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.22e-05	0.00127	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	5.21e-05	0.00127	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.1e-05	0.00125	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	5.07e-05	0.00124	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5e-05	0.00122	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5e-05	0.00122	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.91e-05	0.0012	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.81e-05	0.00117	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.77e-05	0.00116	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.77e-05	0.00116	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.74e-05	0.00116	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.68e-05	0.00114	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.52e-05	0.0011	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.39e-05	0.00107	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.36e-05	0.00106	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.33e-05	0.00106	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.3e-05	0.00105	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.23e-05	0.00103	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.17e-05	0.00102	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.15e-05	0.00101	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.13e-05	0.00101	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.000995	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.98e-05	0.00097	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.87e-05	0.000945	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.72e-05	0.000907	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.66e-05	0.000894	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.61e-05	0.000881	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.45e-05	0.000843	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000836	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.36e-05	0.000821	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	3.36e-05	0.00082	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.33e-05	0.000811	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.32e-05	0.00081	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.26e-05	0.000796	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000778	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000768	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.12e-05	0.000762	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.000673	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.68e-05	0.000655	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.57e-05	0.000626	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.5e-05	0.000609	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.4e-05	0.000586	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.37e-05	0.000579	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.23e-05	0.000544	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.2e-05	0.000538	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.14e-05	0.000523	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.14e-05	0.000522	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.05e-05	0.0005	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.00049	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.99e-05	0.000486	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.91e-05	0.000466	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000448	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.81e-05	0.000443	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.7e-05	0.000415	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.69e-05	0.000413	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.69e-05	0.000411	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000404	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.65e-05	0.000404	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000387	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000375	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000372	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.000358	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.45e-05	0.000354	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000323	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000314	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000311	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000306	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000297	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.17e-05	0.000286	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000285	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000282	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000263	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000258	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.000248	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1e-05	0.000245	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.34e-06	0.000228	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.03e-06	0.00022	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.93e-06	0.000218	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.85e-06	0.000216	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.15e-06	0.000199	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.11e-06	0.000198	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8e-06	0.000195	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.54e-06	0.000184	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.51e-06	0.000183	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.46e-06	0.000182	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.21e-06	0.000176	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.07e-06	0.000172	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.26e-06	0.000153	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.18e-06	0.000151	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.02e-06	0.000147	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.76e-06	0.00014	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.75e-06	0.00014	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.45e-06	0.000133	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.8e-06	0.000117	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.6e-06	0.000112	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-06	9.05e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-06	8.66e-05	CbGpPWpGaD
